New Blood Test Identifies Individuals at Risk of Heart Attack
Assessment focuses on vascular inflammation (February 13)
Validation has been completed on a new blood test that aims to identify individuals who are at risk of a heart attack that might be missed by conventional tests. These individuals have no symptoms and frequently have normal standard blood-cholesterol profiles, but are at significant risk of having a heart attack in the near term.
The Myocardial Assessment Profile (MAP) test covers pathways involved in unstable cardiac lesions due to inflammation, which is the most common cause of heart attacks (up to 75%).
The new test will be offered globally, with a focus on nations where there has been a steep rise in cardiac disease, obesity, and diabetes.
According to the product’s developer (HealthMed Holdings), the MAP test measures compounds in the blood associated with vascular inflammation causing unstable cardiac lesions. Measurement of these compounds in serum allows the identification of individuals at risk of a heart attack in the near term. The test enables physicians to more effectively manage and treat their patients to the new ACC/AHA cardiac guidelines, HealthMed says.
Source: PR Newswire; February 13, 2014.